DAIICHI SANKYO COMPANY, LIMITED
(Public, TYO:4568) Watch this stockFind more results for
4568
Advertisement
Events
Jan 29, 2010
Q3 2010 Earnings Release
- 12:30PM JST -
Dec 11, 2009
R&D Meeting (Japanese)
- 10:00AM JST -
Oct 30, 2009
Q2 2010 Earnings Conference Call and Webcast (Japanese) -
Oct 30, 2009
Q2 2010 Earnings Release
|
|
Key stats and ratios
| Q3 (Sep '09) | 2009 | |
| Net profit margin | 13.25% | -27.20% |
| Operating margin | 18.71% | -35.09% |
| EBITD margin | - | 14.25% |
| Return on average assets | 8.70% | -15.36% |
| Return on average equity | 11.75% | -20.43% |
| Employees | 29,272 | - |
Address
3-5-1 Nihonbashi-Honcho
Chuo-ku, TKY 103-8426
Japan
+81-3-62251017 (Phone)
Chuo-ku, TKY 103-8426
Japan
+81-3-62251017 (Phone)
Website links
DAIICHI SANKYO COMPANY, LIMITED discussions
Giuen Holding Trust Ltd. Financial Derivatives
CWMTrader - Oct 27, 2008 (1 post)
Global Fund Guide - Pension Portfolio (PP) - Economic Time Package Endowment Management – An Investment Adviser’s Perspective The endowment fiduciary’s primary task, in my judgement, is the establishment of a charitable ...
CWMTrader - Oct 27, 2008 (1 post)
Global Fund Guide - Pension Portfolio (PP) - Economic Time Package Endowment Management – An Investment Adviser’s Perspective The endowment fiduciary’s primary task, in my judgement, is the establishment of a charitable ...
Description
DAIICHI SANKYO COMPANY, LIMITED is a Japan-based holding company mainly engaged in the manufacturing and sale of pharmaceuticals. The Company has two business segments. The Pharmaceuticals segment is involved in the research, development, manufacturing and sale of pharmaceuticals, as well as the provision of intermediates and basic materials for pharmaceutical making. The Others segment is involved in the real estate leasing, the insurance agency business, as well as the provision of human affairs and accounting services.
Officers and directors
| Kiyoshi Morita | Chairman of the Executive Board, Representative Director | |
| Takashi Shoda | Executive President, Representative Director | |
| Ryoichi Kifusa | Executive Officer, Manager of Tokyo Office | |
| Tsutomu Une | Senior Managing Executive Officer, Director | |
| Ryuzo Takada | Senior Managing Executive Officer, Director | |
| Hitoshi Matsuda | Senior Managing Executive Officer, Director | |
| Takeshi Ogita | Senior Managing Executive Officer, Director | |
| Yoshihiko Suzuki | Managing Executive Officer, Chief Director of Medicine Sales | |
| Yoshikazu Takano | Managing Executive Officer | |
| Toru Kuroda | Managing Executive Officer, Chief Director of Supply Chain |